Eugenia Corrales-Aguilar

Dr. Eugenia Corrales-Aguilar

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2014 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ECEugenia Corrales-Aguilar
Eugenia Corrales-Aguilar
Mirko TrillingMirko Trilling
Mirko Trilling
KHKatja Hunold
Katja Hunold
MFManuela Fiedler
Manuela Fiedler
VLVu Thuy Khanh Le
Vu Thuy Khanh Le
HHHartmut Hengel
Hartmut Hengel
Human cytomegalovirus (HCMV) establishes lifelong infection with recurrent episodes of virus production and shedding despite the presence of adaptive immunological memory responses including HCMV immune immunoglobulin G (IgG). Very little is known how HCMV evades from humoral and cellular IgG-dependent immune responses, the latter being executed by cells expressing surface receptors for the Fc domain of IgG (FcγRs). Remarkably, HCMV expresses the RL11-encoded gp34 and UL119-118-encoded gp68 type I transmembrane glycoproteins which bind Fcγ with nanomolar affinity. Using a newly developed FcγR activation assay, we tested if the HCMV-encoded Fcγ binding proteins (HCMV FcγRs) interfere with individual host FcγRs. In absence of gp34 or/and gp68, HCMV elicited a much stronger activation of FcγRIIIA/CD16, FcγRIIA/CD32A and FcγRI/CD64 by polyclonal HCMV-immune IgG as compared to wildtype HCMV. gp34 and gp68 co-expression culminates in the late phase of HCMV replication coinciding with the emergence of surface HCMV antigens triggering FcγRIII/CD16 responses by polyclonal HCMV-immune IgG. The gp34- and gp68-dependent inhibition of HCMV immune IgG was fully reproduced when testing the activation of primary human NK cells. Their broad antagonistic function towards FcγRIIIA, FcγRIIA and FcγRI activation was also recapitulated in a gain-of-function approach based on humanized monoclonal antibodies (trastuzumab, rituximab) and isotypes of different IgG subclasses. Surface immune-precipitation showed that both HCMV-encoded Fcγ binding proteins have the capacity to bind trastuzumab antibody-HER2 antigen complexes demonstrating simultaneous linkage of immune IgG with antigen and the HCMV inhibitors on the plasma membrane. Our studies reveal a novel strategy by which viral FcγRs can compete for immune complexes against various Fc receptors on immune cells, dampening their activation and antiviral immunity. Herpes viruses persist lifelong continuously alternating between latency and virus production and transmission. The latter events occur despite the presence of immune IgG antibodies. IgG acts by neutralization of virions and activation of immune cells bearing one or more surface receptors, called FcγRs, recognizing the constant Fc domain of IgG. Activating FcγRs induce a wide range of immune responses, including antibody dependent cellular cytotoxicity (ADCC) of virus-infected cells by natural killer (NK) cells, cytokine secretion and the uptake of immune complexes to enhance antigen presentation to T cells. We demonstrate that the HCMV glycoproteins RL11/gp34 and UL119-118/gp68 block IgG-mediated activation of FcγRs. A novel reporter cell-based assay was used to test FcγRs individually and assess their relative susceptibility to each antagonist. This approach revealed that gp34 and gp68 block triggering of activating FcγRs, i.e. FcγRI (CD64), FcγRII (CD32A) and FcγRIII (CD16). Co-immunoprecipitation showed the formation of ternary complexes containing IgG, IgG-bound antigen and the viral antagonists on the cell surface. Assigning the redundant abilities of HCMV to hinder IgG effector responses to the viral Fc binding proteins, we discuss gp34 and gp68 as potential culprits which might contribute to the limited efficacy of therapeutic IgG against HCMV.

7 October 2014 in Seminars in Immunopathology
Verified
Journal Article
Closed access
PDF file
ECEugenia Corrales-Aguilar
Eugenia Corrales-Aguilar
KHKatja Hoffmann
Katja Hoffmann
HHHartmut Hengel
Hartmut Hengel

1 January 2013 in Journal of Immunological Methods
Verified
Journal Article
Closed access
ECEugenia Corrales-Aguilar
Eugenia Corrales-Aguilar
Mirko TrillingMirko Trilling
Mirko Trilling
HRHenrike Reinhard
Henrike Reinhard
EMEva Mercé-Maldonado
Eva Mercé-Maldonado
MWMarek Widera
Marek Widera
HHHartmut Hengel
Hartmut Hengel

1 September 2015 in Ticks and Tick-borne Diseases
Verified
Journal Article
Closed access
JRJuan J. Rivas
Juan J. Rivas
AMAndrés Moreira-Soto
Andrés Moreira-Soto
GAGilberth Alvarado
Gilberth Alvarado
LTLizeth Taylor
Lizeth Taylor
OCOlger Calderón-Arguedas
Olger Calderón-Arguedas
ATAdriana Troyo
Adriana Troyo

18 May 2017 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
AVAmanda Vicente-Santos
Amanda Vicente-Santos
AMAndres Moreira-Soto
Andres Moreira-Soto
CSClaudio Soto-Garita
Claudio Soto-Garita
LCLuis Guillermo Chaverri
Luis Guillermo Chaverri
ACAndrea Chaves
Andrea Chaves
ECEugenia Corrales-Aguilar
Eugenia Corrales-Aguilar
Several studies have shown Dengue Virus (DENV) nucleic acids and/or antibodies present in Neotropical wildlife including bats, suggesting that some bat species may be susceptible to DENV infection. Here we aim to elucidate the role of house-roosting bats in the DENV transmission cycle. Bats were sampled in households located in high and low dengue incidence regions during rainy and dry seasons in Costa Rica. We captured 318 bats from 12 different species in 29 households. Necropsies were performed in 205 bats to analyze virus presence in heart, lung, spleen, liver, intestine, kidney, and brain tissue. Histopathology studies from all organs showed no significant findings of disease or infection. Sera were analyzed by PRNT90 for a seroprevalence of 21.2% (51/241), and by PCR for 8.8% (28/318) positive bats for DENV RNA. From these 28 bats, 11 intestine samples were analyzed by RT-PCR. Two intestines were DENV RNA positive for the same dengue serotype detected in blood. Viral isolation from all positive organs or blood was unsuccessful. Additionally, viral load analyses in positive blood samples by qRT-PCR showed virus concentrations under the minimal dose required for mosquito infection. Simultaneously, 651 mosquitoes were collected using EVS-CO2 traps and analyzed for DENV and feeding preferences (bat cytochrome b). Only three mosquitoes were found DENV positive and none was positive for bat cytochrome b. Our results suggest an accidental presence of DENV in bats probably caused from oral ingestion of infected mosquitoes. Phylogenetic analyses suggest also a spillover event from humans to bats. Therefore, we conclude that bats in these urban environments do not sustain DENV amplification, they do not have a role as reservoirs, but function as epidemiological dead end hosts for this virus. Dengue is the most important human vector-borne disease. Several studies have shown DENV presence in mammalian wildlife such as bats, thus considering them putative reservoirs or hosts. We aimed to elucidate if bats that cohabit in houses in close proximity with humans may be involved in a dengue transmission cycle. We sampled bats in low and high dengue incidence areas during the dry (low mosquito abundance) and wet (high mosquito abundance) seasons. We analyzed blood and several organs. As previously reported, we found DENV nucleic acid and neutralizing antibodies in a small percentage of blood samples, but virus detection in all organs was negative. We were able to show that dengue found in all positive samples was in low concentration and thus virus isolation was unsuccessful. We found positive intestine samples which may suggest infection through DENV-positive mosquito ingestion. Furthermore, mosquitoes sampled in close vicinity of bats’ roosting place were not feeding on these mammals. Virus sequence analysis from bats and humans show a spillover effect from humans to bats. Taken together, our results indicate that bats do not sustain sufficient virus amplification in order to function as reservoirs and exclude them as players in the dengue virus transmission cycle.

1 August 2021 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
Jose Arturo Arturo MoraJose Arturo Arturo Mora
Jose Arturo Arturo Mora
ECEstela Cordero-Laurent
Estela Cordero-Laurent
AGAdriana Godínez
Adriana Godínez
MCMelany Calderón-Osorno
Melany Calderón-Osorno
HBHebleen Brenes
Hebleen Brenes
FDFrancisco Javier Duarte-Martínez
Francisco Javier Duarte-Martínez